LDL resistance to oxidation: Effects of lipid phenotype, autologous HDL and alanine

被引:5
|
作者
Baldi, Simona
Frascerra, Silvia
Ferrannini, Ele
Natali, Andrea
机构
[1] Univ Pisa, Sch Med, Dept Internal Med, I-56100 Pisa, Italy
[2] Univ Pisa, Sch Med, CNR, Inst Clin Physiol, I-56100 Pisa, Italy
关键词
LDL oxidation; lag phase; HDL oxidation; anti-oxidants;
D O I
10.1016/j.cca.2006.12.019
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although LDL resistance to copper-induced oxidation is a time-honoured method, how it is modulated by the physiologic variability of lipid phenotype and what influences the protective action of homologous HDL and exogenous alanine is still unclear. Methods: In 159 subjects without severe dyslipidemias, LDL resistance to copper-induced oxidation (lag phase) was measured under standardised conditions, with alanine and with autologous HDL. Results: Lag phase was normally distributed and averaged 68 +/- 10 min (range: 40-105 min). Both VLDL-triglycerides (37 +/- 5, 52 +/- 7, 59 +/- 7, 53 +/- 5 mg/dl, p<0.05) and LDL-triglycerides (27 +/- 2, 27 +/- 1, 30 +/- 2, 35 +/- 3 mg/dl, p<0.01) increased across quartiles of lag phase. The relative LDL enrichment in triglycerides (triglycerides percent or triglycerides/cholesterol ratio) was strongly related to lag phase (r=0.29 and r=0.31, p<0.0005 for both) independently of age, gender, BMI, and presence of diabetes or hypertension. The protective effect of HDL was variable (+42 +/- 18 min) and largely dependent on the capacity of HDL to resist oxidation (r=0.69,p<0.0001). Alanine induced a rather constant lag phase prolongation (+32 +/- 7 min) that was weakly related only to baseline lag phase (r=0.17,p<0.05). Conclusions: Relative triglyceride abundance protects LDL from ex-vivo oxidation, HDL particles protect LDL mainly through substrate dilution and alanine probably through a direct anti-oxidant effect. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
  • [41] Navigating Lipid Discrepancies: Implications for Cardiovascular Risk With LDL, Non-HDL, LDL-P, and ApoB
    Hassan, Sharjeel
    Triffon, Douglas W.
    CIRCULATION, 2024, 149
  • [42] ANTIOXIDANTS AND RESISTANCE AGAINST OXIDATION OF PIG LDL
    KNIPPING, G
    ROTHENEDER, M
    STRIEGL, G
    ESTERBAUER, H
    ARTERIOSCLEROSIS, 1990, 10 (05): : A796 - A797
  • [43] Effect of lemon flavonoids on resistance of LDL to oxidation
    Usuda, M
    Sakurai, C
    Uto, H
    Tago, M
    Tani, M
    Kido, T
    Nghiem, TN
    Miyake, Y
    Sakaida, K
    Kiyose, C
    Suzuki, E
    Kondo, K
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 278 - 279
  • [44] Kale extracts increase the resistance of LDL to oxidation
    Kucuk, N.
    Kural, B. Vanizor
    Orem, A.
    FEBS JOURNAL, 2008, 275 : 380 - 380
  • [45] Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults
    Badiou, S
    De Boever, CM
    Dupuy, AM
    Baillat, V
    Cristol, JP
    Reynes, J
    ATHEROSCLEROSIS, 2004, 172 (02) : 273 - 279
  • [46] Nitric oxide inhibition of peroxynitrite-dependent LDL and HDL oxidation.
    Batthyány, C
    Trostchansky, A
    Botti, H
    Sanguinetti, S
    Radi, R
    Rubbo, H
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 : S76 - S76
  • [47] The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers
    Kuvin, JT
    Karas, RH
    CURRENT OPINION IN CARDIOLOGY, 2003, 18 (04) : 295 - 300
  • [48] JOINT EFFECTS OF SERUM TRIGLYCERIDES AND LDL AND HDL CHOLESTEROL - REPLY
    MANNINEN, V
    KOSKINEN, P
    MANTTARI, M
    FRICK, MH
    TENKANEN, L
    HUTTUNEN, JK
    HEINONEN, OP
    CIRCULATION, 1993, 87 (01) : 301 - 301
  • [49] Inhibitory Effects of Balsamic Vinegar on LDL Oxidation and Lipid Accumulation in THP-1 Macrophages
    Iizuka, Maki
    Tani, Mariko
    Kishimoto, Yoshimi
    Saita, Emi
    Toyozaki, Miku
    Kondo, Kazuo
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2010, 56 (06) : 421 - 427
  • [50] Effects of smoking on LDL oxidation in vivo
    Vasankari, TJ
    Vasankari, TM
    Ahotupa, M
    Terho, EO
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 219 - 219